Edgewise Therapeutics Ownership | Who Owns Edgewise Therapeutics?

Edgewise Therapeutics Ownership Summary

Edgewise Therapeutics is owned by 113.13% institutional investors, 0.44% insiders. Orbimed advisors is the largest institutional shareholder, holding 14.79% of EWTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.68% of its assets in Edgewise Therapeutics shares.

EWTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Edgewise Therapeutics	113.13%	0.44%	-13.57%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	15.52M	14.79%	$203.45M
Ra capital management	9.90M	9.44%	$129.82M
Baker bros. advisors lp	7.31M	6.96%	$95.78M
Blackrock	6.02M	6.87%	$108.34M
Blackrock funding, inc. /de	6.78M	6.46%	$88.90M
Janus henderson group	4.98M	5.31%	$133.04M
Novo	5.35M	5.10%	$70.14M
Braidwell lp	5.21M	4.97%	$68.31M
Paradigm biocapital advisors lp	4.49M	4.79%	$119.99M
Vanguard group	4.47M	4.76%	$119.26M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	1.03M	25.51%	$13.51M
Orbimed advisors	15.52M	5.10%	$203.45M
Novo	5.35M	4.95%	$70.14M
Foresite capital management vi	585.00K	4.31%	$7.67M
Paradigm biocapital advisors lp	4.49M	4.17%	$119.99M
Cormorant asset management, lp	4.25M	4.15%	$55.74M
Bioimpact capital	1.72M	3.91%	$22.56M
First light asset management	1.71M	2.91%	$22.47M
Sio capital management	539.73K	2.70%	$7.08M
Braidwell lp	5.21M	2.34%	$68.31M

Top Buyers

Holder	Shares	% Assets	Change
Braidwell lp	5.21M	2.34%	2.75M
Paradigm biocapital advisors lp	4.49M	4.17%	1.70M
Siren	3.16M	2.14%	1.46M
Bellevue group	2.78M	0.80%	1.35M
Baker bros. advisors lp	7.31M	0.93%	1.15M

Top Sellers

Holder	Shares	% Assets	Change
Tcg crossover management	-	-	-2.11M
Perceptive advisors	4.64M	2.26%	-1.91M
Deep track capital, lp	-	-	-1.40M
Frazier life sciences management	-	-	-1.27M
Ecor1 capital	-	-	-1.25M

New Positions

Holder	Shares	% Assets	Change	Value
Sio capital management	539.73K	2.70%	539.73K	$7.08M
Eversept partners, lp	392.74K	0.47%	392.74K	$5.15M
Voloridge investment management	284.55K	0.01%	284.55K	$3.73M
Kynam capital management, lp	253.98K	0.36%	253.98K	$3.33M
Campbell & co investment adviser	114.18K	0.09%	114.18K	$1.50M

Sold Out

Holder	Change
Pnc financial services group	-4.00
Nelson, van denburg & campbell wealth management group	-8.00
Creekmur asset management	-8.00
Newedge advisors	-9.00
Capital performance advisors llp	-20.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	182	-15.35%	118,716,112	13.87%	113	0.94%	118	13.46%	39	-40.00%
Mar 31, 2025	214	1.42%	105,276,596	6.36%	110	0.99%	104	-14.05%	63	5.00%
Dec 31, 2024	67	-64.55%	17,838,374	-82.39%	19	0.16%	35	-68.75%	20	-53.49%
Sep 30, 2024	188	33.33%	101,300,175	-0.31%	107	0.80%	112	23.08%	43	48.28%
Jun 30, 2024	141	9.30%	101,619,838	10.90%	116	1.06%	91	1.11%	29	3.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.82M	2.68%	-62.61K
Vanguard US Total Market Shares ETF	2.54M	2.67%	-5.23K
iShares Russell 2000 ETF	1.73M	1.64%	-32.76K
BB Biotech AG Ord	1.43M	1.51%	-
Fidelity Small Cap Growth	983.35K	1.05%	-284.60K
Polar Capital Biotech S Inc	975.00K	0.93%	-
Artisan International Small-Mid Investor	914.19K	0.87%	281.23K
Artisan Non-U.S. Small-Mid Growth Comp	914.19K	0.87%	281.23K
Janus Henderson Global Life Sciences	838.14K	0.80%	153.58K
Janus Henderson Global Life Sciences D	838.14K	0.80%	-8.23K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 12, 2025	MOORE JOHN R	General Counsel	Sell	$28.10K
Aug 12, 2025	Derakhshan Behrad	Chief Business Officer	Sell	$33.36K
Aug 12, 2025	Carruthers R Michael	Chief Financial Officer	Sell	$19.12K
Aug 12, 2025	Russell Alan J	Chief Scientific Officer	Sell	$25.54K
Aug 12, 2025	KOCH KEVIN	President and CEO	Sell	$106.76K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	6
2025 Q2	4	6
2025 Q1	-	8
2024 Q4	-	3
2024 Q3	-	10

EWTX Ownership FAQ

Who Owns Edgewise Therapeutics?

Edgewise Therapeutics shareholders are primarily institutional investors at 113.13%, followed by 0.44% insiders and -13.57% retail investors. The average institutional ownership in Edgewise Therapeutics's industry, Biotech Stocks , is 304.14%, which Edgewise Therapeutics falls below.

Who owns the most shares of Edgewise Therapeutics?

Edgewise Therapeutics’s largest shareholders are Orbimed advisors (15.52M shares, 14.79%), Ra capital management (9.9M shares, 9.44%), and Baker bros. advisors lp (7.31M shares, 6.96%). Together, they hold 31.19% of Edgewise Therapeutics’s total shares outstanding.

Does Blackrock own Edgewise Therapeutics?

Yes, BlackRock owns 6.87% of Edgewise Therapeutics, totaling 6.02M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 108.34M$. In the last quarter, BlackRock increased its holdings by 848.7K shares, a 16.43% change.

Who is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested, with 25.51% of its assets in 1.03M Edgewise Therapeutics shares, valued at 13.51M$.

Who is the top mutual fund holder of Edgewise Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Edgewise Therapeutics shares, with 2.68% of its total shares outstanding invested in 2.82M Edgewise Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools